Important Safety Information on the Association of Zevalin (ibritumomab tiuxetan) with severe mucocutaneous reactions- Notice to Hospitals- Berlex Canada Inc.
Issued December 7, 2005
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker